MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1176/appi.ps.20240138

Медицинская библиотека · Psychiatric services (Washington, D.C.) · 2024

Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study.

Bareis Natalie, Edlund Mark, Ringeisen Heather, Guyer Heidi, Dixon Lisa B, Olfson Mark, Smith Thomas E, Chwastiak Lydia, Monroe-DeVita Maria, Swartz Marvin, Swanson Jeffrey, Sinclair Hancq Elizabeth, Geiger Paul, Kreski Noah T, Stroup T Scott

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVE

Current information on treatment and clinical characteristics of U.S. adults with schizophrenia spectrum disorders (i.e., schizophrenia, schizoaffective, and schizophreniform disorders) may help inform public health policy and service development for this population.

METHODS

Data were from the U.S. Mental and Substance Use Disorders Prevalence Study, conducted from October 2020 to October 2022. Clinicians administered the Structured Clinical Interview for the DSM-5 for past-year psychiatric and substance use disorder diagnoses among adults ages 18-65 years. Using sampling weights, the authors examined clinical and treatment characteristics among those with schizophrenia spectrum disorders and compared sociodemographic characteristics and comorbid behavioral health conditions of individuals with or without such disorders (N=4,764).

RESULTS

Among 114 adults with schizophrenia spectrum disorders, the most common comorbid conditions were major depressive episode (52%, 95% CI=34%-69%) and alcohol use (23%, CI=3%-43%), cannabis use (20%, 95% CI=1%-39%), and posttraumatic stress (17%, 95% CI=5%-30%) disorders. Global Assessment of Functioning scores were lower among people with than among those without schizophrenia spectrum disorders (mean±SE=44.8±2.0 vs. 77.2±0.5, p<0.01, respectively), indicating worse functioning. In the past year, 71% (95% CI=55%-87%) of adults with schizophrenia spectrum disorders received at least some mental health treatment, and 26% (95% CI=13%-38%) received minimally adequate treatment.

CONCLUSIONS

Individuals with schizophrenia spectrum disorders face substantial challenges in the United States, including high rates of comorbid mental health conditions and substance use; few received adequate treatment. A strong social safety net and active clinical interventions are required to address the socioeconomic challenges and unmet mental health service needs of this population.

Для цитирования: Bareis Natalie, Edlund Mark, Ringeisen Heather, Guyer Heidi, Dixon Lisa B, Olfson Mark, Smith Thomas E, Chwastiak Lydia, Monroe-DeVita Maria, Swartz Marvin, Swanson Jeffrey, Sinclair Hancq Elizabeth, Geiger Paul, Kreski Noah T, Stroup T Scott. Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study.. Psychiatric services (Washington, D.C.). 2024. DOI: 10.1176/appi.ps.20240138.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.